Diagnosis and treatment of orphan disease — homocystinuria and megaloblastic anemia, type cblG

The term «homocystinuria» combines a number of genetically determined nosological forms caused by defects of the metabolism of sulfur-containing amino acids (methionine, homocysteine), cobalamin and folate. The group of these diseases includes «classical» homocystinuria caused by insufficiency of cystathionine beta-synthase and forms associated with defects in methionine remethylation processes. More information is given about one of these forms — homocystinuria and megaloblastic anemia, type cblG, caused by MTR gene mutations. The results of observation of a child with this disease are presented. The clinical status includes: intellectual disability, autistic behavioral traits, stereotypes, nystagmus, visual impairment, macrocytic anemia, epilepsy in remission. Effective treatment requires the use of medications not registered in the Russian Federation — betaine and hydroxocobalamin.

[1]  J. Thevenon,et al.  The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders , 2021, Molecular genetics and metabolism reports.

[2]  I. Rudan,et al.  Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence , 2018, Journal of global health.

[3]  M. Baumgartner,et al.  Newborn screening for homocystinurias: Recent recommendations versus current practice , 2018, Journal of inherited metabolic disease.

[4]  E. Nikolaeva,et al.  Clinical and Molecular Characteristics of Russian Patients with Homocystinuria due to Cystathionine Beta-Synthase Deficiency , 2018 .

[5]  W. Craigen,et al.  Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. , 2017, Molecular genetics and metabolism.

[6]  M. Baumgartner,et al.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency , 2016, Journal of Inherited Metabolic Disease.

[7]  I. T. de Almeida,et al.  Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency , 2016, Journal of Inherited Metabolic Disease.

[8]  M. Thall,et al.  Neuropsychiatric Illness in a Patient with Cobalamin G Disease, an Inherited Disorder of Vitamin B12 Metabolism , 2004, Harvard review of psychiatry.